SIGNAL AS A TOOL OF THE PHARMACOVIGILANCE
The European Medical Agency (EMA) in 2012 formulated modern legislation defining the procedure for pharmacovigilance — the Good Pharmacovigilance Practices (GVP), which replaced the earlier provisions of the Pharmacovigilance Guidelines for Human Medicines. The signal management position is included...
Saved in:
| Main Authors: | E. O. Zhuravleva, N. Yu. Velts, G. V. Kutekhova, M. A. Darmostukova, R. N. Alyautdin |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»
2018-06-01
|
| Series: | Безопасность и риск фармакотерапии |
| Subjects: | |
| Online Access: | https://www.risksafety.ru/jour/article/view/102 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Statistical signal detection methods
by: K. E. Zatolochina, et al.
Published: (2018-02-01) -
Exploring the complexities of disproportionality analysis in pharmacovigilance: reflections on the READUS-PV guideline and a call to action
by: Tarek A. Hammad, et al.
Published: (2025-04-01) -
Influence of differential source patterns in the detection of signals of disproportionate reporting for PARP inhibitors
by: Jordi Mestres, et al.
Published: (2024-12-01) -
Comparative Analysis of International Databases of Adverse Drug Reactions
by: A. S. Kazakov, et al.
Published: (2020-09-01) -
Quantitative Signal Detection for COVID-19 Medicinal Products Based on Retrospective Analysis of Spontaneous Reports from the Russian Pharmacovigilance Database
by: S. A. Mishinova, et al.
Published: (2024-04-01)